CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 266 enrolled
Drug / intervention
SLActive dental implantdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00782171
NCT00782171Phase 4Completed
CompareCT.gov

Immediate and Delayed Loading of 4.1 mm and 4.8 mm Implants in the Posterior Mandible & Maxilla: A Controlled Randomized Study of Single or 2-4 Unit Restorations Loaded Immediately After Surgery or Four Weeks After Surgery

Institut Straumann AG·interventional·Posted Oct 31, 2008·Updated Jun 20, 2017

In Brief

A Phase 4 clinical trial evaluating SLActive dental implant for Partial Edentulism. Completed, enrolled 266 participants across 19 sites in 9 countries.

Detailed Summary

The purpose of this study is to evaluate the performance of a new dental implant with a modified surface in different loading protocols.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPartial Edentulism
CountriesAustria, Germany, Ireland, Netherlands, Portugal, Spain, Sweden, Switzerland, United States
Collaborators--

Timeline

Phase 4CompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 31, 2008
Enrollment StartJul 1, 2004
Primary CompletionOct 1, 2006
Study CompletionFeb 1, 2010
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 17.7 years ago

Interventions

SLActive dental implantdevice

Straumann® SLActive implants will be placed. Implants in Arm 1 will be restored with a temporary restoration on the day of surgery. Implants in Arm 2 will receive healing caps immediately after surgery and a provisional restoration will be placed between day 28 to day 34 post-surgery. In both arms, the final restoration will be placed between 140 and 160 days (20 to 23 weeks) post-surgery.